School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
Mol Med Rep. 2017 Oct;16(4):4075-4081. doi: 10.3892/mmr.2017.7072. Epub 2017 Jul 21.
To identify novel candidate genes associated with osteoporosis, RNA‑sequence analysis of human mesenchymal stem cells (hMSCs) from patients with osteoporosis (G3) and osteopenia (G2), and healthy controls (G1) was performed. Differentially expressed genes (DEGs) from among the three groups were identified. DEGs were separated into nine groups according to their gene expression patterns: UU (up and up), UF (up and flat), UD (up and down), FU (flat and up), FF (flat and flat), FD (flat and down), DU (down and up), DF (down and flat), and DD (down and down). Among the 42 DEGs between G3 and G1, eight candidate genes, namely stimulated by retinoic acid 6 (STRA6), melanophilin, neurotrophic receptor tyrosine kinase 2, cartilage oligomeric matrix protein, collagen type XI α 1 chain, integrin subunit β 2, monooxygenase DBH‑like 1 and selenoprotein P, were selected, as they demonstrated consistent gene expression patterns of UU, FU, FD, and DD. Among these eight genes, STRA6 was highly expressed in the osteoporosis group and based on additional data from quantitative polymerase chain reaction analysis, it was selected for further study. In order to investigate whether STRA6 served a functional role in osteoblast or adipocyte differentiation, the effects of STRA6 expression changes in pluripotent stem cell C3H10T1/2, preosteoblast MC3T3‑E1 and stromal ST2 cell lines were examined. Bone morphogenetic protein 2 enhanced STRA6 expression only at the early stage of osteoblast differe-ntiation, and overexpression of STRA6 temporally inhibited the expression of osteoblastogenesis markers, including runt related transcription factor 2, bone sialoprotein and osteocalcin. Furthermore, the knockdown of STRA6 slightly enhanced nodule formation at the late stage of osteoblast differentiation, and overexpression of STRA6 in ST2 cells enhanced adipocyte differentiation. Taken together, STRA6 expression could be associated with the pathogenesis of osteoporosis by promoting adipocyte differentiation over osteoblast differentiation in the hMSC population.
为了鉴定与骨质疏松症相关的新型候选基因,对骨质疏松症(G3)和骨量减少症(G2)患者以及健康对照者(G1)的人骨髓间充质干细胞(hMSC)进行了 RNA 测序分析。从这三组中鉴定出差异表达基因(DEG)。根据基因表达模式将 DEG 分为九组:UU(上调和上调)、UF(上调和平坦)、UD(上调和下调)、FU(平坦和上调)、FF(平坦和平坦)、FD(平坦和下调)、DU(下调和上调)、DF(下调和平坦)和 DD(下调和下调)。在 G3 和 G1 之间的 42 个 DEG 中,选择了 8 个候选基因,即维甲酸诱导基因 6(STRA6)、黑素磷蛋白、神经营养受体酪氨酸激酶 2、软骨寡聚基质蛋白、胶原 XI 型α1 链、整合素亚基β2、单加氧酶 DBH 样 1 和硒蛋白 P,因为它们表现出一致的 UU、FU、FD 和 DD 基因表达模式。在这 8 个基因中,STRA6 在骨质疏松症组中高表达,基于定量聚合酶链反应分析的额外数据,选择其用于进一步研究。为了研究 STRA6 是否在成骨细胞或脂肪细胞分化中发挥功能作用,检测了 STRA6 表达变化对多能干细胞 C3H10T1/2、前成骨细胞 MC3T3-E1 和基质 ST2 细胞系的影响。骨形态发生蛋白 2 仅在成骨细胞分化的早期增强 STRA6 的表达,并且 STRA6 的过表达暂时抑制成骨细胞生成标志物的表达,包括 runt 相关转录因子 2、骨唾液蛋白和骨钙素。此外,STRA6 的敲低在成骨细胞分化的晚期稍微增强了结节形成,并且 STRA6 在 ST2 细胞中的过表达增强了脂肪细胞分化。总之,STRA6 的表达可能通过促进 hMSC 群体中的脂肪细胞分化而不是成骨细胞分化,与骨质疏松症的发病机制有关。